PFIZER INC — Director's Dealing 2022

Oct 13, 2022

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Pyxis Oncology, Inc. (PYXS)
CIK: 0001782223
Period of Report: 2022-10-06

Reporting Person: PFIZER INC (10% Owner)
Reporting Person: Pfizer Ventures (US) LLC (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock, $0.001 par value per share	4140669	Direct
Common Stock, $0.001 par value per share	1080507	Indirect

Footnotes

F1: The shares are owned directly by Pfizer Ventures (US) LLC, which is a wholly owned subsidiary of Pfizer Inc.